Apraxias: Clinical Trials

4 trials for Apraxias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Not yet recruiting 1, Terminated 1
Phase 11Terminated 1

Follow Apraxias: new trials by email Literature Review of Apraxias trials Research Report on Apraxias

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Omega-DEK in Childhood Apraxia of Speech
Omega-DEK, L-carnitine, Placebo - Childhood Apraxia of Speech, Verbal Apraxia
Phase 2Not yet recruitingClaudia R. Morris342026-11-012026-07-29
Methylphenidate in Childhood Apraxia of Speech
Methylphenidate Hydrochloride, Placebo - Childhood Apraxia of Speech
Phase 2CompletedMurdoch Childrens Research Institute182022-03-142026-10-13
Evaluating Anodal tDCS Preceding Aphasia Therapy
transcranial direct current stimulation - Stroke, Aphasia
Phase 1 / Phase 2TerminatedNorthwell Health152014-09-012021-04-05
Electrical Polarization of the Brain in Corticobasal Syndrome
Phoresor II - Corticobasal Syndrome
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)202005-12-302017-07-02

Narrower conditions

Aphasia (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Autistic Disorder (1)  ·  Communication Disorders (1)  ·  Corticobasal Degeneration (1)  ·  Dementia (1)  ·  Speech Intelligibility (1)  ·  Stroke (1)

Broader conditions

Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Neurobehavioral Manifestations (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Psychomotor Disorders (4)  ·  Signs and Symptoms (4)  ·  Neurodevelopmental Disorders (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Behavior (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)

Interventions

Carnitine (1)  ·  Methylphenidate (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

Claudia R. Morris (1)  ·  Murdoch Childrens Research Institute (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Northwell Health (1)

Countries

United States (3)  ·  Australia (1)

Top investigators

Angela Morgan, PhD (1)  ·  Claudia R Morris, MD (1)  ·  Lawrence Scahill, MSN,PhD (1)